Current HIV Research, Volume 11 - Number 5

Editorial (Thematic Issue: Fc Receptor-Mediated Effector Functions in the Humoral Control of HIV-1 Infection)

, 11(5): 343 - 344

Anthony DeVico

DOI: 10.2174/1570162X113116660056

Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts

, 11(5): 345 - 353

Alan L. Schmaljohn

DOI: 10.2174/1570162X113116660057

Qualitative and Quantitative Variables that Affect the Potency of Fc- Mediated Effector Function In Vitro and In Vivo: Considerations for Passive Immunization Using Non-Neutralizing Antibodies

, 11(5): 354 - 364

George K Lewis

DOI: 10.2174/1570162X113116660060

Opportunities to Exploit Non-Neutralizing HIV-Specific Antibody Activity

, 11(5): 365 - 377

Margaret E. Ackerman and Galit Alter

DOI: 10.2174/1570162X113116660058

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses

, 11(5): 378 - 387

Justin Pollara, Mattia Bonsignori, M. Anthony Moody, Marzena Pazgier, Barton F. Haynes and Guido Ferrari

DOI: 10.2174/1570162X113116660059

HIV-Specific Antibody Immunity Mediated Through NK Cells and Monocytes

, 11(5): 388 - 406

Marit Kramski, Matthew S. Parsons, Ivan Stratov and Stephen J. Kent

DOI: 10.2174/1570162X113116660061

Fc Receptor-Mediated Immune Responses: New Tools But Increased Complexity in HIV Prevention

, 11(5): 407 - 420

Diego A. Vargas-Inchaustegui and Marjorie Robert-Guroff

DOI: 10.2174/1570162X113116660063

Antibody-Dependent Enhancement and the Risk of HIV Infection

, 11(5): 421 - 426

Andrea Gorlani and Donald N. Forthal

DOI: 10.2174/1570162X113116660062

HIV-1 Variable Loop 2 and its Importance in HIV-1 Infection and Vaccine Development

, 11(5): 427 - 438

Mangala Rao, Kristina K. Peachman, Jiae Kim, Guofen Gao, Carl R. Alving, Nelson L. Michael and Venigalla B. Rao

DOI: 10.2174/1570162X113116660064

Webmaster Contact:
Copyright © 2018 Bentham Science